ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

131 hedge funds and large institutions have $221M invested in iTeos Therapeutics in 2025 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

13% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 23

16% less capital invested

Capital invested by funds: $262M → $221M (-$41.5M)

78% less call options, than puts

Call options by funds: $1.02M | Put options by funds: $4.67M

Holders
131
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.02M
Puts
$4.67M
Net Calls
Net Calls Change

Top Buyers

1 +$14.7M
2 +$9.29M
3 +$4.97M
4
BI
BVF Inc
California
+$4.48M
5
BlackRock
BlackRock
New York
+$4.23M

Top Sellers

1 -$7.27M
2 -$4.98M
3 -$2.17M
4
CM
Caption Management
Oklahoma
-$2.12M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.51M